These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30450823)

  • 61. A Review of
    Purwaningsih I; Maksum IP; Sumiarsa D; Sriwidodo S
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770960
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence.
    Sarris J; Panossian A; Schweitzer I; Stough C; Scholey A
    Eur Neuropsychopharmacol; 2011 Dec; 21(12):841-60. PubMed ID: 21601431
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression.
    Rybakowski JK; Suwalska A; Lojko D; Rymaszewska J; Kiejna A
    J Affect Disord; 2005 Feb; 84(2-3):141-7. PubMed ID: 15708411
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Advances and controversies in medical treatment of depression].
    Llop Rius R; Rodríguez Cumplido D; Danés Carreras I; Capellà Hereu D
    Aten Primaria; 2003 Feb; 31(3):194-7. PubMed ID: 12622988
    [No Abstract]   [Full Text] [Related]  

  • 65. Berberine and barberry (Berberis vulgaris): A clinical review.
    Imenshahidi M; Hosseinzadeh H
    Phytother Res; 2019 Mar; 33(3):504-523. PubMed ID: 30637820
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Natural products of relevance in the prevention and supportive treatment of depression.
    Muszyńska B; Łojewski M; Rojowski J; Opoka W; Sułkowska-Ziaja K
    Psychiatr Pol; 2015; 49(3):435-53. PubMed ID: 26276913
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characteristics of depressive and bipolar disorder patients with mixed features.
    Tondo L; Vázquez GH; Pinna M; Vaccotto PA; Baldessarini RJ
    Acta Psychiatr Scand; 2018 Sep; 138(3):243-252. PubMed ID: 29862493
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune-based strategies for mood disorders: facts and challenges.
    Colpo GD; Leboyer M; Dantzer R; Trivedi MH; Teixeira AL
    Expert Rev Neurother; 2018 Feb; 18(2):139-152. PubMed ID: 29179585
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuroprotective effects of antidepressant and mood stabilizing drugs.
    Young LT
    J Psychiatry Neurosci; 2002 Jan; 27(1):8-9. PubMed ID: 11836978
    [No Abstract]   [Full Text] [Related]  

  • 70. Second-tier natural antidepressants: review and critique.
    Iovieno N; Dalton ED; Fava M; Mischoulon D
    J Affect Disord; 2011 May; 130(3):343-57. PubMed ID: 20579741
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Berberine and inflammatory bowel disease: A concise review.
    Habtemariam S
    Pharmacol Res; 2016 Nov; 113(Pt A):592-599. PubMed ID: 27697643
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lipid-lowering effect of berberine in human subjects and rats.
    Hu Y; Ehli EA; Kittelsrud J; Ronan PJ; Munger K; Downey T; Bohlen K; Callahan L; Munson V; Jahnke M; Marshall LL; Nelson K; Huizenga P; Hansen R; Soundy TJ; Davies GE
    Phytomedicine; 2012 Jul; 19(10):861-7. PubMed ID: 22739410
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preclinical models: status of basic research in depression.
    Nestler EJ; Gould E; Manji H; Buncan M; Duman RS; Greshenfeld HK; Hen R; Koester S; Lederhendler I; Meaney M; Robbins T; Winsky L; Zalcman S
    Biol Psychiatry; 2002 Sep; 52(6):503-28. PubMed ID: 12361666
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Berberine: new perspectives for old remedies.
    Tillhon M; Guamán Ortiz LM; Lombardi P; Scovassi AI
    Biochem Pharmacol; 2012 Nov; 84(10):1260-7. PubMed ID: 22842630
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epigenetic Drugs for Mood Disorders.
    Peedicayil J; Kumar A
    Prog Mol Biol Transl Sci; 2018; 157():151-174. PubMed ID: 29933949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antidepressant effects of the herb Salvia divinorum: a case report.
    Hanes KR
    J Clin Psychopharmacol; 2001 Dec; 21(6):634-5. PubMed ID: 11763023
    [No Abstract]   [Full Text] [Related]  

  • 77. Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012.
    Kanba S; Kato T; Terao T; Yamada K;
    Psychiatry Clin Neurosci; 2013 Jul; 67(5):285-300. PubMed ID: 23773266
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Berberine pharmacology and the gut microbiota: A hidden therapeutic link.
    Habtemariam S
    Pharmacol Res; 2020 May; 155():104722. PubMed ID: 32105754
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Berberine: A Traditional Natural Product With Novel Biological Activities.
    Hou Q; He WJ; Wu YS; Hao HJ; Xie XY; Fu XB
    Altern Ther Health Med; 2020 Jul; 26(S2):20-27. PubMed ID: 31634873
    [TBL] [Abstract][Full Text] [Related]  

  • 80. GABA and glutamate systems as therapeutic targets in depression and mood disorders.
    Kendell SF; Krystal JH; Sanacora G
    Expert Opin Ther Targets; 2005 Feb; 9(1):153-68. PubMed ID: 15757488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.